Avandia may raise osteoporosis risk
(AP)
<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20071202/ap_on_he_me/diabetes_osteoporosis"><img src="http://d.yimg.com/us.yimg.com/p/ap/20071202/capt.nyol70712022148.diabetes_osteoporosis_nyol707.jpg?x=130&y=77&sig=GXcszrE1SapzsnesTK8efw--" align="left" height="77" width="130" alt="Moncef Slaoui,, chairman of Research and Development at GalaxoSmithKline is seen on Capitol Hill in Washington, Wednesday, June 6, 2007, after testifying before the House Oversight and Government Reform committee hearing on the diabetes drug Avandia. (AP Photo/Susan Walsh)" border="0" /></a>AP - The popular diabetes drug marketed as Avandia may increase bone thinning, a discovery that could help explain why diabetics can have an increased risk of fractures.</p><br clear="all"/>

Read more...